Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: Prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction

Journal of Neurosurgery

Volumn 106, Issue 5, 2007, Pages 881-886

  Ansar, Saema ^a,b   Svendgaard, Niels Aage ^b   Edvinsson, Lars ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

5 HT 1B receptor; Cerebral blood flow; Cerebral ischemia; ETB receptor; Neurokinin 1 receptor; Rat; Subarachnoid hemorrhage

Indexed keywords

5 CARBAMOYLTRYPTAMINE; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; L 822429; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SARAFOTOXIN; SEROTONIN 1B RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN BLOOD FLOW; BRAIN REGION; CONTROLLED STUDY; DRUG MECHANISM; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; UPREGULATION;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENTRICULAR; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, NEUROKININ-1; REGIONAL BLOOD FLOW; SUBARACHNOID HEMORRHAGE; UP-REGULATION; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 34247862253     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2007.106.5.881     Document Type: Article

References (46)

1. Alafaci C, Jansen I, Arbab MA, Shiokawa Y, Svendgaard NA, Edvinsson L: Enhanced vasoconstrictor effect of endothelin in cerebral arteries from rats with subarachnoid haemorrhage. Acta Physiol Scand 138:317-319, 1990
2. Armstrong DM, Pickel VM, Joh TH, Reis DJ, Miller RJ: Immunocytochemical localization of catecholamine synthesizing enzymes and neuropeptides in area postrema and medial nucleus tractus solitarius of rat brain. J Comp Neurol 196:505-517, 1981
3. Asano T: Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions. Crit Rev Neurosurg 9:303-318, 1999
4. Baker KG, Halliday GM, Hornung JP, Geffen LB, Cotton RG, Tork I: Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neuroscience 42:757-775, 1991
5. Beg SA, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI: ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-hT(1B) receptor upregulation after subarachnoid hemorrhage in rat. J Cereb Blood Flow Metab 26:846-856, 2006
6. Conley RK, Cumberbatch MJ, Mason GS, Williamson DJ, Harrison T, Locker K, et al: Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity. J Neurosci 22:7730-7736, 2002
7. Cook DA: Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol Ther 66:259-284, 1995
8. Delgado TJ, Brismar J, Svendgaard NA: Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16:595-602, 1985
9. Delgado-Zygmunt T, Shiokawa Y, Arbab MA, Svendgaard NA: Effect of spantide, a substance-P antagonist, on cerebral vasospasm in primates. Acta Neurochir (Wien) 122:122-126, 1993
10. Delgado-Zygmunt TJ, Arbab MA, Edvinsson L, Jansen I, Svendgaard NA: Prevention of cerebral vasospasm in the rat by depletion or inhibition of substance P in conducting vessels. J Neurosurg 72:917-925, 1990
11. Ebner K, Rupniak NM, Saria A, Singewald N: Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci U S A 101:4280-4285, 2004
12. Edvinsson L, Egund N, Owman C, Sahlin C, Svendgaard NA: Reduced noradrenaline uptake and retention in cerebrovascular nerves associated with angiographically visible vasoconstriction following experimental subarachnoid hemorrhage in rabbits. Brain Res Bull 9:799-805, 1982
13. Edvinsson L, Juul R, Jansen I: Perivascular neuropeptides (NPY, VIP, CGRP and SP) in human brain vessels after subarachnoid haemorrhage. Acta Neurol Scand 90:324-330, 1994
14. Edvinsson L, Krause DN (eds): Cerebral Blood Flow and Metabolism, ed 2. Philadelphia: Lippincott Williams & Wilkins, 2001
15. Fiebich BL, Schleicher S, Butcher RD, Craig A, Lieb K: The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. J Immunol 165:5606-5611, 2000
16. Findlay JM, Weir BK, Kanamaru K, Espinosa F: Arterial wall changes in cerebral vasospasm. Neurosurgery 25:736-746, 1989
17. Gjedde A, Hansen AJ, Siemkowicz E: Rapid simultaneous determination of regional blood flow and blood-brain glucose transfer in brain of rat. Acta Physiol Scand 108:321-330, 1980
18. Hahn MK, Bannon MJ: Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation. Neuroscience 94:1183-1188, 1999
19. Hansen-Schwartz J, Hoel NL, Xu CB, Svendgaard NA, Edvinsson L: Subarachnoid hemorrhage-induced upregulation of the 5-hT1B receptor in cerebral arteries in rats. J Neurosurg 99:115-120, 2003
20. Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB, Svendgaard NA, Edvinsson L: Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 52:1188-1195, 2003
21. Hansen-Schwartz J, Nordstrom CH, Edvinsson L: Human endothelin subtype A receptor enhancement during tissue culture via de novo transcription. Neurosurgery 50:127-135, 2002
22. Hansen-Schwartz J, Svensson CL, Xu CB, Edvinsson L: Protein kinase mediated upregulation of endothelin A, endothelin B and 5-hydroxytryptamine 1B/1D receptors during organ culture in rat basilar artery. Br J Pharmacol 137:118-126, 2002
23. Hoel NL, Hansen-Schwartz J, Edvinsson L: Selective up-regulation of 5-hT(1B/1D) receptors during organ culture of cerebral arteries. Neuroreport 12:1605-1608, 2001
24. Kanamaru K, Weir BK, Findlay JM, Krueger CA, Cook DA: Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage. J Neurosurg 71:909-915, 1989
25. Macdonald RL, Marton LS, Andrus PK, Hall ED, Johns L, Sajdak M: Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogs. Life Sci 75:979-989, 2004
26. Mann CV, Russell RCG: Bailey & Love's Short Practice of Surgery, ed 21. London: Chapman & Hall, 1992
27. Mantyh PW, Hunt SP, Maggio JE: Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand. Brain Res 307:147-165, 1984
28. Mayberg MR, Houser OW, Sundt TM Jr: Ultrastructural changes in feline arterial endothelium following subarachnoid hemorrhage. J Neurosurg 48:49-57, 1978
29. Navari RM, Reinhardt RR, Gralla RJ, Kris MG, Hesketh PJ, Khojasteh A, et al: Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754, 030 Antiemetic Trials Group. N Engl J Med 340:190-195, 1999
30. Nozaki K, Okamoto S, Yanamoto H, Kikuchi H: Red blood cells are essential for late vasospasm following experimentally induced subarachnoid hemorrhage in dogs. Neurol Med Chir (Tokyo) 30:10-15, 1990
31. Peterson JW, Roussos L, Kwun BD, Hackett JD, Owen CJ, Zervas NT: Evidence of the role of hemolysis in experimental cerebral vasospasm. J Neurosurg 72:775-781, 1990
32. Pluta RM: Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 105:23-56, 2005
33. Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA: Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 52:165-176, 2003
34. Prunell GF, Mathiesen T, Svendgaard NA: A new experimental model in rats for study of the pathophysiology of subarachnoid hemorrhage. Neuroreport 13:2553-2556, 2002
35. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T: Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 56:1082-1092, 2005
36. Rigby M, O'Donnell R, Rupniak NM: Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain. J Comp Neurol 490:335-353, 2005
37. Rupniak NM, Kramer MS: Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 20:485-490, 1999
38. Sakurada O, Kennedy C, Jehle J, Brown JD, Carbin GL, Sokoloff L: Measurement of local cerebral blood flow with iodo [14C] antipyrine. Am J Physiol 234:H59-H66, 1978
39. Shiokawa Y, Holst JJ, Torben J, Rasmussen N, Schmidt P, Svendgaard NA: Cerebrovascular changes following administration of gammaglobulins against substance P or calcitonin gene related peptide in monkey with subarachnoid haemorrhage. Br J Neurosurg 7:507-518, 1993
40. Shiokawa Y, Svendgaard NA: Cerebrovascular sensory innervation involved in the development of cerebral vasospasm following a subarachnoid hemorrhage. J Auton Nerv Syst 49 (Suppl):S167-S170, 1994
41. Svendgaard NA, Shiokawa Y, Delgado-Zygmunt TJ, Arbab MA, Skagerberg G, Brun A: Effect of lesioning of medullary catecholamine neurons or the median eminence on the development of cerebral vasospasm in the squirrel monkey. Acta Neurochir (Wien) 118:137-145, 1992
42. Tamiya R, Hanada M, Kawai Y, Inagaki S, Takagi H: Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat. Neurosci Lett 110:11-15, 1990
43. Turner CP, Panter SS, Sharp FR: Anti-oxidants prevent focal rat brain injury as assessed by induction of heat shock proteins (HSP70, HO-1/HSP32, HSP47) following subarachnoid injections of lysed blood. Brain Res Mol Brain Res 65:87-102, 1999
44. Zervas NT: Vasospasm: an update. Clin Neurosurg 26:643-656, 1979
45. Zervas NT, Lavyne MH, Negoro M: Neurotransmitters and the normal and ischemic cerebral circulation. N Engl J Med 293:812-816, 1975
46. Zimmermann M, Seifert V: Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 43:863-876, 1998